These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 18703470)

  • 21. [Stable ischemic coronary disease--medical therapy or PCI?].
    Mickley H; Egstrup K
    Ugeskr Laeger; 2007 Jun; 169(23):2227. PubMed ID: 17607849
    [No Abstract]   [Full Text] [Related]  

  • 22. Outcome of patients with stable angina pectoris treated with or without percutaneous coronary intervention.
    Gu Y; Hu Y; Hu L; Cheng Z; Li L
    Cardiol J; 2008; 15(3):226-9. PubMed ID: 18651414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention.
    Muller O; Hamilos M; Bartunek J; Ulrichts H; Mangiacapra F; Holz JB; Ntalianis A; Trana C; Dierickx K; Vercruysse K; De Bruyne B; Wijns W; Barbato E
    Am J Cardiol; 2010 Feb; 105(3):333-8. PubMed ID: 20102944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the efficacy and safety of pharmacological treatment versus percutaneous coronary angioplasty in patients with intermediate coronary artery lesions.
    Latacz P; Rostoff P; Gackowski A; El-Massri N; Konduracka E; Gajos G; Matysek J; Piwowarska W; Zmudka K
    Kardiol Pol; 2009 Aug; 67(8A):1004-12. PubMed ID: 19784905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life with PCI versus medical therapy in stable coronary disease.
    Brown RA; Teirstein PS; Kandzari DE
    N Engl J Med; 2008 Nov; 359(21):2291; author reply 2292-3. PubMed ID: 19031543
    [No Abstract]   [Full Text] [Related]  

  • 26. The long-term cost-effectiveness of clopidogrel plus aspirin in patients undergoing percutaneous coronary intervention in Sweden.
    Lindgren P; Stenestrand U; Malmberg K; Jönsson B
    Clin Ther; 2005 Jan; 27(1):100-10. PubMed ID: 15763611
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life with PCI versus medical therapy in stable coronary disease.
    Beltrame JF; Tavella R; Cutri N
    N Engl J Med; 2008 Nov; 359(21):2289-90; author reply 2292. PubMed ID: 19020332
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of difficulty affording health care on health status after coronary revascularization.
    Spertus J; Decker C; Woodman C; House J; Jones P; O'Keefe J; Borkon AM
    Circulation; 2005 May; 111(20):2572-8. PubMed ID: 15883210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Late outcomes after drug-eluting stent implantation in "real-world" clinical practice.
    Ramsdale DR; Rao A; Asghar O; Ramsdale KA; McKay E
    J Invasive Cardiol; 2008 Oct; 20(10):493-500. PubMed ID: 18829991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience.
    Maegdefessel L; Schlitt A; Faerber J; Bond SP; Messow CM; Buerke M; Raaz U; Werdan K; Muenzel T; Weiss C
    Med Klin (Munich); 2008 Sep; 103(9):628-32. PubMed ID: 18813885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term cost-effectiveness of early and sustained clopidogrel therapy for up to 1 year in patients undergoing percutaneous coronary intervention after presenting with acute coronary syndromes without ST-segment elevation.
    Mahoney EM; Mehta S; Yuan Y; Jackson J; Chen R; Gabriel S; Lamy A; Culler S; Caro J; Yusuf S; Weintraub WS;
    Am Heart J; 2006 Jan; 151(1):219-27. PubMed ID: 16368322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Quality of life following percutaneous coronary interventions in octogenarians].
    Kaehler J; Koester R; Hamm CW; Meinertz T
    Dtsch Med Wochenschr; 2005 Mar; 130(12):639-43. PubMed ID: 15776345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The editor's roundtable: chronic stable angina pectoris.
    Friedewald VE; King SB; Pepine CJ; Vetrovec GW; Roberts WC
    Am J Cardiol; 2007 Dec; 100(11):1635-43. PubMed ID: 18036361
    [No Abstract]   [Full Text] [Related]  

  • 34. Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.
    Motovska Z; Kala P
    Clin Ther; 2008; 30 Pt 2():2191-202. PubMed ID: 19281914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery.
    Gurfinkel EP; Perez de la Hoz R; Brito VM; Duronto E; Dabbous OH; Gore JM; Anderson FA;
    Int J Cardiol; 2007 Jun; 119(1):65-72. PubMed ID: 17045681
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention.
    Wolfram RM; Torguson RL; Hassani SE; Xue Z; Gevorkian N; Pichard AD; Satler LF; Kent KM; Waksman R
    Am J Cardiol; 2006 Apr; 97(7):984-9. PubMed ID: 16563901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality of life with PCI versus medical therapy in stable coronary disease.
    Reppel M; Radke PW; Schunkert H
    N Engl J Med; 2008 Nov; 359(21):2290-1; author reply 2292. PubMed ID: 19031542
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent.
    Wang ZJ; Zhou YJ; Liu YY; Yu M; Shi DM; Zhao YX; Guo YH; Cheng WJ; Jia de A; Cao Z; Nie B; Ge HL; Yang SW; Yan ZX
    Thromb Res; 2009 May; 124(1):46-51. PubMed ID: 19041120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short- and long-term health related quality-of-life and anginal status of the Arterial Revascularisation Therapies Study part II, ARTS-II; sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease.
    van Domburg RT; Daemen J; Morice MC; de Bruyne B; Colombo A; Macaya C; Richardt G; Fajadet J; Hamm C; van Es GA; Wittebols K; Macours N; Stoll HP; Serruys PW
    EuroIntervention; 2010 Apr; 5(8):962-7. PubMed ID: 20542782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantifying the early health status benefits of successful chronic total occlusion recanalization: Results from the FlowCardia's Approach to Chronic Total Occlusion Recanalization (FACTOR) Trial.
    Grantham JA; Jones PG; Cannon L; Spertus JA
    Circ Cardiovasc Qual Outcomes; 2010 May; 3(3):284-90. PubMed ID: 20388873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.